Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 10/2020

01-10-2020 | Glomerulonephritis | Correction

Correction to: Temporal change in life and renal prognosis of rapidly progressive glomerulonephritis in Japan via nationwide questionnaire survey

Authors: Kunihiro Yamagata, Joichi Usui, Hitoshi Sugiyama, Shoichi Maruyama, Ichiei Narita

Published in: Clinical and Experimental Nephrology | Issue 10/2020

Login to get access

Excerpt

In the Original publication of the article, the text in the horizontal axis in Fig. 1a and b appears incorrectly as “Time from treatment start (Months)”. The corrected Fig. 1 is given below …
Metadata
Title
Correction to: Temporal change in life and renal prognosis of rapidly progressive glomerulonephritis in Japan via nationwide questionnaire survey
Authors
Kunihiro Yamagata
Joichi Usui
Hitoshi Sugiyama
Shoichi Maruyama
Ichiei Narita
Publication date
01-10-2020
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 10/2020
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-020-01901-z

Other articles of this Issue 10/2020

Clinical and Experimental Nephrology 10/2020 Go to the issue

Images in Nephrology

A Nautilus kidney

Original article

Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis

Original article

The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD)

Original article

Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria

Original article

Arteriovenous fistulas after ultrasound-guided needle biopsy of kidney allografts and treatment outcomes after transcatheter embolization: A single-center experience in Japan

Original article

Development of prognostic model for patients at CKD stage 3a and 3b in South Central China using computational intelligence
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits